Examining the Feasibility of Surgery Omission After Neoadjuvant Systemic Therapy in Invasive Breast Cancer
home / oncclub / examining-the-feasibility-of-surgery-omission-after-neoadjuvant-systemic-therapy-in-invasive
Henry M. Kuerer, MD, PhD, FACS, CMQ, discusses lessons learned from a nonrandomized clinical trial evaluating selective elimination of surgery for invasive breast cancer.
